Table 2.
Comparison between groups for the patient-reported outcomes.
| Independent Variable | Sexual Problems (SAS) | Need for Counselling (NSCS-CHF) | Health-Related Quality of Life (MLHFQ) | ||||
|---|---|---|---|---|---|---|---|
| Mean (SD) | p-Value | Mean (SD) | p-Value | Mean (SD) | p-Value | ||
| Sex | <0.01 * | 0.01 * | 0.12 | ||||
| Male | 6.72 (3.86) | 2.39 (0.68) | 29.39 (20.57) | ||||
| Female | 3.79 (3.12) | 1.89 (0.74) | 37.7 (19.87) | ||||
| Age | <0.01 * | 0.74 | 0.48 | ||||
| <63 | 4.71 (3.84) | 2.23 (0.74) | 30.08 (22.56) | ||||
| 63–79 | 7.49 (3.44) | 2.29 (0.72) | 33.47 (17.96) | ||||
| Country | 0.54 | 0.15 | 0.38 | ||||
| Belgium | 5.76 (3.85) | 2.2 (0.72) | 32.82 (21.55) | ||||
| Italy | 6.47 (4.09) | 2.56 (0.74) | 27.94 (16.88) | ||||
| Beta Blocker generation | 0.79 | 0.87 | 0.19 | ||||
|
Generation 2
Generation 3 |
5.86 (3.85) 5.58 (3.5) |
2.25 (0.72) 2.29 (0.65) |
32.04 (19.9) 24.74 (20.67) |
||||
| Etiology HF | 0.15 | 0.25 | 0.91 | ||||
| Ischemic | 6.59 (3.98) | 2.12 (0.82) | 31.43 (22.64) | ||||
| Non-ischemic | 5.18 (3.81) | 2.34 (0.65) | 31.97 (18.03) | ||||
| Hypertension | 0.48 | 0.62 | 0.28 | ||||
| Yes | 6.27 (4.03) | 2.16 (0.8) | 29.11 (21.27) | ||||
| No | 5.53 (4.03) | 2.27 (0.68) | 34.72 (19.78) | ||||
| Hyperlipidemia | <0.01 * | <0.01 * | 0.17 | ||||
| Yes | 6.71 (3.91) | 2.37 (0.69) | 33.04 (21.67) | ||||
| No | 3.67 (3.31) | 1.81 (0.68) | 25.58 (13.17) | ||||
| Diabetes | 0.11 | 0.48 | 0.15 | ||||
| Yes | 6.88 (3.97) | 2.3 (0.77) | 36.04 (23.44) | ||||
| No | 5.26 (3.87) | 2.17 (0.72) | 28.71 (18.01) | ||||
| NYHA | <0.01 * | 0.09 | <0.01 * | ||||
|
Class I
Class II Class III |
2.36 (1.6) 5.73 (3.81) 9.13 (2.8) |
1.73 (0.72) 2.29 (0.7) 2.65 (0.88) |
20.78 (19.27) 29.55 (18.31) 55.5 (17.19) |
||||
* significant at p < 0.01 level. HF, heart failure.